An Industry Perspective on the State of Confusion in International ADR Reporting: Current Requirements and Attempts at Standardization

Abstract

Keywords

Worldwide regulations Expedited adverse event reporting Periodic clinical-safety reports CIOMS projects

Get full access to this article

View all access options for this article.

References

Gordon

Petrick

. Worldwide regulations for manufacturers on clinical safety surveillance of drugs. Drug Inf J. 1992;26: 1–15.

International Reporting of Adverse Drug Reactions. Final Report of CIOMS Working Group, CIOMS, 1990, WHO, Avenue Appia, 1211 Geneva 27, Switzerland.

Guidelines for Participation of Pharmaceutical Laboratories in the Spanish Drug Surveillance Scheme, Guidelines No. 39/91, Directorate General of Pharmacy and Health Products, Madrid, Spain.

International Reporting of Periodic Drug-Safety Update Summaries. Final Report of CIOMS Working Group II, CIOMS, 1992, WHO, Avenue Appia, 1211 Geneva 27, Switzerland.

Castle

. The Report of the CIOMS II Working Group. Pharmacoepidemiology and Drug Safety. 1992;1: 53–54.